Human Metabolome Technologies, Inc. announced that Dr. Alexander Buko has joined the executive team in a newly created position as Vice President of HMT America reporting to President Tsutotmu Hoshiba. Dr. Buko brings with him over 30 years of pharmaceutical experience with the FDA, Abbott Labs, and most recently with Biogen Idec where he held the position of Senior Director of Translational Medicine. Alex has successfully led large scale omics projects in neurology, immunology and oncology.

With extensive experience in protein and metabolite based profiling, Alex will lead project management and develop HMT's biomarker based platforms.